Engineering IscB to develop highly efficient miniature editing tools in mammalian cells and embryos
Molecular Cell · 2024-08 · 84 (16) · 3128-3140.e4
DOI: 10.1016/j.molcel.2024.07.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2024-08. Verfasst von Niannian Xue und 15 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences…. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Shanghai Municipality Science and Technology Commission, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
The IscB proteins, as the ancestors of Cas9 endonuclease, hold great promise due to their small size and potential for diverse genome editing. However, their activity in mammalian cells is unsatisfactory. By introducing three residual substitutions in IscB, we observed an average 7.5-fold increase in activity. Through fusing a sequence-non-specific DNA-binding protein domain, the eIscB-D variant achieved higher editing efficiency, with a maximum of 91.3%. Moreover, engineered ωRNA was generated with a 20% reduction in length and slightly increased efficiency. The engineered eIscB-D/eωRNA system showed an average 20.2-fold increase in activity compared with the original IscB. Furthermore, we successfully adapted eIscB-D for highly efficient cytosine and adenine base editing. Notably, eIscB-D is highly active in mouse cell lines and embryos, enabling the efficient generation of disease models through mRNA/ωRNA injection. Our study suggests that these miniature genome-editing tools have great potential for diverse applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai,…
- Bioray Laboratories Inc., Shanghai, China.
- Department of Biological Sciences, Department of Biochemistry, Precision Medicine Translational Research Programme (TRP), National University of Singapore, Singapore.
Förderung
- Shanghai Municipality Science and Technology Commission
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Ministry of Science and Technology of the People's Republic of China
- East China Normal University
Zitieren
APA
Xue, N., Hong, D., Zhang, D., Wang, Q., Zhang, S., Yang, L., Chen, X., Li, Y., Han, H., Hu, C., Liu, M., Song, G., Guan, Y., Wang, L., Zhu, Y., & Li, D. (2024). Engineering IscB to develop highly efficient miniature editing tools in mammalian cells and embryos. Molecular Cell, 84(16), 3128-3140.e4. https://doi.org/10.1016/j.molcel.2024.07.007
Vancouver
Xue N, Hong D, Zhang D, Wang Q, Zhang S, Yang L, et al. Engineering IscB to develop highly efficient miniature editing tools in mammalian cells and embryos. Molecular Cell. 2024;84(16):3128-3140.e4. doi:10.1016/j.molcel.2024.07.007
BibTeX
@article{Xue2024,
author = {Xue, Niannian and Hong, Dishan and Zhang, Dan and Wang, Qian and Zhang, Shun and Yang, Lei and Chen, Xi and Li, Yongmei and Han, Honghui and Hu, Chunyi and Liu, Mingyao and Song, Gaojie and Guan, Yuting and Wang, Liren and Zhu, Yifan and Li, Dali},
title = {Engineering IscB to develop highly efficient miniature editing tools in mammalian cells and embryos},
journal = {Molecular Cell},
year = {2024},
volume = {84},
number = {16},
pages = {3128--3140.e4},
doi = {10.1016/j.molcel.2024.07.007}
}
EUVIMED